Election aftermath: implications for life sciences companies 

Related topics
Life sciences
Financial services
Global trade
Health
Tax
Tax planning
Trust
Watch on-demand

Join us for an insightful webcast where we examine the implications of the 2024 election results on the life sciences sector. With President-elect Donald Trump set to return to the White House and Republicans poised to control both the House and Senate, the landscape for life sciences is expected to undergo significant changes — both welcomed and challenging.

In this webcast, subject-matter advisors will explore key priorities of the incoming Trump administration, including:

  • Trade, Tariffs, and Taxes: Examining the potential changes in trade policies, tariffs and tax regulations and their impact on the life sciences sector
  • Lowering drug prices: Understanding the potential impact of new statutory authorities from the Inflation Reduction Act (IRA) and how international reference pricing might be refashioned for Medicare Part B and Part D programs
  • Drug supply chain: Understanding how the global drug supply chain could shift and the impact of new trade, tariff and tax policies 
  • Health care price transparency: Insights into the bipartisan efforts to codify transparency rules and the future of transparency measures for pharmacy benefit managers (PBMs)
  • Federal Trade Commission (FTC) approach: Anticipating a more favorable transaction market and the implications for life sciences companies
  • Congressional reforms: Potential broader reforms via the budget reconciliation process, including the future of the IRA and its impact on pharmaceutical innovation and investment appeal

Speakers:

 

Webcast

Total duration: 60 minutes

Time

your local time

Related webcasts

Special post-election edition: Tax in a time of transition

In this webcast, panelists discuss the US economy and tax policy, what’s happening at the IRS and breaking developments.

Global economic outlook: post-election macro and geopolitical trends

In this webcast, panelists discuss the US economic outlook for 2025 in the aftermath of the US election, geopolitical dynamics and more.

    EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.